Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.94
-0.29-3.14%
At close: Feb 13, 4:00 PM EST
$9.45
0.515.70%
After Hours: Feb 11, 4:00 PM EST
Comments
Loading...
Crescent Biopharma Inc (CBIO) Stock Price, Quote, News & History
CBIONASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Crescent Biopharma (CBIO) stock?
You can purchase shares of Crescent Biopharma (NASDAQ:CBIO) through any online brokerage.
Who are Crescent Biopharma (CBIO) competitors?
Other companies in Crescent Biopharma’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Burning Rock Biotech Ltd (NASDAQ:BNR), Immuneering Corp (NASDAQ:IMRX), Larimar Therapeutics Inc (NASDAQ:LRMR) and Armata Pharmaceuticals Inc (AMEX:ARMP).
What is the forecast, or price target, for Crescent Biopharma (CBIO) stock?
Crescent Biopharma has a consensus price target of $27.17.
What is the current price for Crescent Biopharma (CBIO)?
The stock price for Crescent Biopharma (NASDAQ: CBIO) is $9.45 last updated February 11, 2026 at 4:00 PM EST.
Does Crescent Biopharma (CBIO) pay a dividend?
There are no upcoming dividends for Crescent Biopharma.
When is Crescent Biopharma (NASDAQ:CBIO) reporting earnings?
Crescent Biopharma does not have any upcoming earnings scheduled.
Is Crescent Biopharma (CBIO) going to split?
There is no upcoming split for Crescent Biopharma.
What sector and industry does Crescent Biopharma (CBIO) operate in?
Crescent Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
